Evidence map›Paper›PMID 42246540›Full record

ArticleInvestigative ophthalmology & visual science2026

Stress Responsive bZIP Transcription Factors ATF4 and BACH1 Cooperate With MAF-Family bZIP Protein NRL to Fine-Tune Rod Photoreceptor Gene Expression.

Kiam Preston, Madhuri Arya, Anjani Kumari, Jacob Nellissery, Matthew J Brooks, Zachary Batz, Xulong Liang, Gianluca Tosini, Anand Swaroop

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kiam PrestonNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Madhuri AryaNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Anjani KumariNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Jacob NellisseryNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Matthew J BrooksNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Zachary BatzNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Xulong LiangNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
Gianluca TosiniDepartment of Pharmacology and Toxicology and Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia, United States.
Anand SwaroopNeurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Musculoaponeurotic fibrosarcoma (MAF) family basic motif leucine zipper (bZIP) transcription factor neural retina leucine zipper (NRL) determines rod cell fate and controls expression of rod genes in concert with multiple regulatory proteins. Mutations in NRL, its targets, and interacting proteins are associated with retinopathies. Because bZIP heterodimerization expands target sequence selectivity, we set out to identify bZIP protein interactors of NRL. Methods: Interactors were identified by yeast two-hybrid and co-immunoprecipitation, validated by high-resolution microscopy and proximity ligation, and functionally assessed by reporter assays. We used Cleavage Under Targets and Tagmentation (CUT&Tag) to map activating transcription factor 4 (ATF4) and BTB and CNC homology 1 (BACH1) occupancy and single-cell RNA sequencing (scRNA-seq) to assess gene expression changes in response to their knockdown in mouse retina. Results: We identified two bZIP proteins, ATF4 and BACH1, as interactors of NRL. We demonstrate a direct interaction of NRL and ATF4 via leucine zipper domain and validate their co-localization in rod photoreceptors. NRL and BACH1 are also partially colocalized, but their interaction likely requires additional factors. Reporter assays show that ATF4 promotes NRL-mediated transactivation of rhodopsin promoter, whereas BACH1 appears to act as a suppressor. CUT&Tag revealed shared and distinct binding sites for NRL, ATF4, and BACH1 in promoters of rod-expressed genes, including phototransduction genes. scRNA-seq further indicated a concordance of higher ATF4 and NRL expression with upregulation of phototransduction genes in distinct rod subpopulations. Conclusions: We suggest that the NRL-mediated gene regulatory network includes transient and stable but context-dependent protein-protein interactions, which control quantitatively precise gene expression patterns in mature rod photoreceptors. Our findings suggest therapeutic potential for retinopathies involving photoreceptor dysfunction through targeted gene expression modulation.

Indexed as

Activating Transcription Factor 4Basic-Leucine Zipper Transcription FactorsEye ProteinsGene Expression RegulationRetinal Rod Photoreceptor CellsAnimalsHumansImmunoprecipitationMiceMice, Inbred C57BLTwo-Hybrid System TechniquesActivating Transcription Factor 4Atf4 protein, mouseBasic-Leucine Zipper Transcription FactorsEye ProteinsNrl protein, mouse

Identifiers

PMID42246540
PMCPMC13249099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.